Synbio Tech Inc. (TPEX:1295)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.00
-0.90 (-1.77%)
May 29, 2026, 1:30 PM CST
Market Cap1.72B -20.9%
Revenue (ttm)1.02B +2.5%
Net Income149.95M -13.1%
EPS4.35 -20.5%
Shares Out 34.48M
PE Ratio11.50
Forward PEn/a
Dividend3.00 (6.00%)
Ex-Dividend DateMar 27, 2026
Volume57,492
Open50.30
Previous Close50.90
Day's Range49.95 - 50.40
52-Week Range49.50 - 157.50
Beta0.65
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Synbio Tech

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 92
Stock Exchange Taipei Exchange
Ticker Symbol 1295
Full Company Profile

Financial Performance

In 2025, Synbio Tech's revenue was 1.04 billion, an increase of 4.97% compared to the previous year's 989.48 million. Earnings were 175.97 million, an increase of 3.43%.

Financial Statements